NEW YORK (GenomeWeb News) – Genetix today announced that it has acquired analysis and data management software firm SlidePath for undisclosed consideration.

Genetix said that the acquisition will complement its offerings in the digital pathology market. Specifically, the Hampshire, UK-based firm said that SlidePath's products will complement its Ariol platform, which is a digital imaging and analysis solution for quantifying biomarkers in tissue sections and tissue microarrays.

SlidePath will continue to operate from its headquarters in Dublin, Ireland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.